Cargando…
Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis
Cancer patients are at a very high risk of serious thrombotic events, often fatal. The causes discussed include the detachment of thrombogenic particles from tumor cells or the adverse effects of chemotherapeutic agents. Cytostatic agents can either act directly on their targets or, in the case of a...
Autores principales: | Krüger-Genge, Anne, Köhler, Susanne, Laube, Markus, Haileka, Vanessa, Lemm, Sandy, Majchrzak, Karolina, Kammerer, Sarah, Schulz, Christian, Storsberg, Joachim, Pietzsch, Jens, Küpper, Jan-Heiner, Jung, Friedrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416884/ https://www.ncbi.nlm.nih.gov/pubmed/37566045 http://dx.doi.org/10.3390/cells12151965 |
Ejemplares similares
-
Investigation of Radiotracer Metabolic Stability In Vitro with CYP-Overexpressing Hepatoma Cell Lines
por: Lemm, Sandy, et al.
Publicado: (2022) -
Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies
por: Braune, Steffen, et al.
Publicado: (2021) -
Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs
por: Laube, Markus, et al.
Publicado: (2019) -
Epigenetics—Shedding Light on the Path Ahead for Material Sciences
por: Krüger-Genge, Anne, et al.
Publicado: (2019) -
NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies
por: Schulz, Christian, et al.
Publicado: (2019)